Editor's ChoiceFOCIS HIGHLIGHTS

Winning with the B team?

See allHide authors and affiliations

Science Immunology  07 Feb 2020:
Vol. 5, Issue 44, eabb0236
DOI: 10.1126/sciimmunol.abb0236

Abstract

The accumulation of B cells and tertiary lymphoid organs in metastatic melanoma patients receiving checkpoint blockade therapy was associated with long-term survival.

View Full Text

Stay Connected to Science Immunology